Towards a fully synthetic MUC1-based anticancer vaccine: efficient conjugation of glycopeptides with mono-, di-, and tetravalent lipopeptides using click chemistry.
about
Strategy for Designing a Synthetic Tumor Vaccine: Multi-Component, Multivalency and Antigen ModificationProtein glycosylation in cancers and its potential therapeutic applications in neuroblastomaAnalysis of carbohydrates and glycoconjugates by matrix-assisted laser desorption/ionization mass spectrometry: An update for 2011-2012.Synthesis and characterisation of self-assembled and self-adjuvanting asymmetric multi-epitope lipopeptides of ovalbumin.Linear synthesis and immunological properties of a fully synthetic vaccine candidate containing a sialylated MUC1 glycopeptide.Pathobiological implications of mucin glycans in cancer: Sweet poison and novel targets.Natural and Induced Humoral Responses to MUC1.Carbohydrate-based cancer vaccines: target cancer with sugar bullets.Multivalent glyco(cyclo)peptides.Therapeutic potential of carbohydrate-based polymeric and nanoparticle systems.Synthesis and Evaluation of GM2-Monophosphoryl Lipid A Conjugate as a Fully Synthetic Self-Adjuvant Cancer Vaccine.'Multicopy multivalent' glycopolymer-stabilized gold nanoparticles as potential synthetic cancer vaccines.Synthetic glycopeptides and glycoproteins with applications in biological research.Direct peptide lipidation through thiol-ene coupling enables rapid synthesis and evaluation of self-adjuvanting vaccine candidates.Peptide Lipidation - A Synthetic Strategy to Afford Peptide Based Therapeutics.Synthesis and Immunological Evaluation of a Multicomponent Cancer Vaccine Candidate Containing a Long MUC1 Glycopeptide.Self-Assembled Nano-Immunostimulant for Synergistic Immune Activation.Multi-component self-assembled anti-tumor nano-vaccines based on MUC1 glycopeptides.Multi-stimuli-responsive chiral organogels based on peptide derivatives.
P2860
Q27001592-F4FA192B-800C-422B-BB54-70CBA42F66D8Q28069952-7AD6B8AA-3B6B-45BD-AA4F-E1CFD5C6F448Q34489424-B08E326C-9DEF-4121-805A-A0E4F8E2552DQ35423378-6557A86B-547B-4C11-9FA6-1C4A8DBA5EB1Q35800918-434D9AFC-EE58-4CA4-9038-04F9FC4747DBQ36328299-64982E01-A5DF-4131-AD3B-769C1804FBC2Q37137385-F0FA4362-B004-4A64-A5A9-DE4EF7648F0EQ38016342-3E1CDE66-A0E0-422C-8060-FC4B1E98A9AAQ38069441-BE58F62D-A264-469D-B2AD-8AD3C3F57BABQ38199152-8A4C09CA-DE92-4877-B22E-1A3EDF620D48Q41194257-469DFBA8-EA72-40E1-B65D-99CCDCB5CE0EQ41965469-462552AB-41E4-462A-8D94-F13D825D61F3Q41983543-20ED76E2-DEE2-49DB-B5F3-489F26417BA3Q46859777-86CB065A-FD58-4D65-B7C9-9BD56BFF13B8Q47590580-31D161E9-FACC-456C-A959-A3B72A578926Q47626278-48698B3D-9077-402B-A0ED-857AB168C18AQ48761437-83AA9E38-78BC-4C56-9F91-201B6C4145B1Q53093803-17EF3B25-FFE9-46B9-92B0-C3CB192DCB22Q53206123-C946017B-26C0-4920-B62F-61D501163DA2
P2860
Towards a fully synthetic MUC1-based anticancer vaccine: efficient conjugation of glycopeptides with mono-, di-, and tetravalent lipopeptides using click chemistry.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Towards a fully synthetic MUC1 ...... eptides using click chemistry.
@en
Towards a fully synthetic MUC1 ...... eptides using click chemistry.
@nl
type
label
Towards a fully synthetic MUC1 ...... eptides using click chemistry.
@en
Towards a fully synthetic MUC1 ...... eptides using click chemistry.
@nl
prefLabel
Towards a fully synthetic MUC1 ...... eptides using click chemistry.
@en
Towards a fully synthetic MUC1 ...... eptides using click chemistry.
@nl
P2093
P2860
P356
P1476
Towards a fully synthetic MUC1 ...... eptides using click chemistry.
@en
P2093
P2860
P304
P356
10.1002/CHEM.201100217
P407
P577
2011-04-27T00:00:00Z